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Results: The results showed that treatment of BNP postconditioning could signiﬁ-
cantly decrease the infarct size and the levels of LDH and CK after 4-h reperfusion (all
P<0.05). BNP postconditioning could also signiﬁcantly inhibit the increases of TNF-
a and IL-6 (both P<0.05). In addition, BNP postconditioning could signiﬁcantly
inhibit HMGB1 expression induced by I/R (P<0.05). Administration of LY294002
abolished the effects of BNP postconditioning on myocardial I/R injury and the ex-
pressions of phospho-Akt and HMGB1 (all P<0.05).
Conclusions: Conclusion: The present study suggests that postconditioning of BNP
could protect against myocardial I/R injury which may be associated with inhibiting
HMGB1 expression, while PI3K/Akt signaling pathway may be involved in the
expression of HMGB1 and the protective effect of BNP postconditioning.
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Objectives: Systemic vasospasm is the fundamental pathological features of pre-
eclampsia, but the mechanism is unclear. Based on the previous studies that there
existed high titers of angiotensin II (ANG II) type 1 receptor (AT1R) autoantibodies
(AT1-AA) in preeclamptic patients, current study aims to discover whether or not
puriﬁed AT1-AA from sera of preeclamptic patients could cause sustained activation
of AT1R on thoracic aortic vascular smooth muscle. If that were the case, molecular
mechanisms of reduced desensitization of AT1R were further explored.
Methods: Afﬁnity chromatography method was used to purify AT1-AA from serum
of 51 preeclampsia patients and negative IgG from serum of 44 normal pregnant
women. Experimental groups are as follows: AT1-AA group (210-6mmol/L);
negative IgG group (210-6mmol/L); ANG II group (210-6mmol/L); losartan (LST)
group (210-6mmol/L AT1-AA+210-5mmol/L LST). In vitro vascular ring tech-
nology was performed to observe the inﬂuence of different treatments on the vascular
tone of rat thoracic aorta; Primary cultured rats’ vascular smooth muscle cells
(VSMCs) were used to detect intracellular calcium ﬂuorescence intensity variance
among different groups under laser scanning confocal microscope; After AT1R-
pcDNA3.1 plasmids were transiently transfected into HEK293 cells, endocytosis
degree of AT1R among different groups were surveyed under laser scanning confocal
microscope.
Results: Different from ANG II which caused transient contraction of aortic rings
(less than 1 minute), AT1-AA can lead to prolonged contraction of isolated rat aortic
rings (more than 30 minutes); AT1-AA can induce long-lasting intracellular calcium
release in cultured VSMCs (17623s vs. 7319s, P<0.01); endocytosis particles
decreased signiﬁcantly on AT1R transiently expressed HEK293 cells after 10 minutes
of AT1-AA administration.
Conclusions: AT1-AA can lead to reduced AT1R desensitization of rat VSMCs which
is different from ANG II and the possible mechanisms was weakened AT1R endo-
cytosis. Our research will provide in-depth and new perspective for understanding the
pathological features of systemic vasospasm in preeclamptic patients which could
contribute to severe clinical symptoms of both mothers and infants.
GW25-e2346
Inhibition of Thioredoxin by Thioredoxin-Interacting Protein Mediates the
Impairment of Ischemia-Induced Angiogenesis in Diabetic Myocardium
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Objectives: Diabetes-induced impairment of collateral formation in ischemic
myocardium has been demonstrated in clinical studies, which may contribute to
unfavorable prognosis among diabetic individuals. However, the underlying
mechanism remains to be deﬁned. In our previous studies, Thioredoxin (Trx) ac-
tivity was shown to be decreased in diabetic cardiac tissues. Thioredoxin-inter-
acting protein (TXNIP), as Trx endogenous inhibitor, is strongly induced by
glucose due to a carbohydrate response element within its promoter. Thus in
present study we aim to determine whether inhibition of Trx by TXNIP exerts a
causative effect on impairment of myocardial ischemia-induced angiogenesis under
diabetic condition and to identify the downstream molecules through in vivo and in
vitro experiments.
Methods: Diabetes was induced by multiple intraperitoneal injections of low-dose
streptozotocin (STZ) in mice. Myocardial infarction (MI) was induced by permanent
occlusion of left anterior descending coronary artery. Small-interfering RNA (siRNA)
targeting TXNIP and recombinant human Trx (rhTrx) was administered intra-
myocardially (4 different sites at the infarct border zone of the left anterior free wall)
and intraperitoneally respectively, immediately after MI. Cardiac function wasJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Bmeasured by echocardiography 30 days after the intervention. The hearts were excised
for immunohistochemical and molecular analysis at predetermined time points. Trx
activity was determined by insulin disulﬁde reduction assay. Human umbilical vein
cord endothelial cells (HUVECs) were treated with or without high glucose medium
for 24 hours. Apoptosis, proliferation, migration and angiogenic capacity of endo-
thelial cells were detected by TUNEL, MTT, Transwell and Matrigel, respectively.
Genes and proteins of interest were detected by Real-time PCR, ELISA, immuno-
precipitation and immunoblotting techniques.
Results: MI-induced myocardial injury was intensiﬁed, evidenced by further
decreased cardiac function and increased ﬁbrosis, along with reduced capillary and
arteriolar density in diabetic mice. Upregulation of TXNIP expression, increased Trx/
TXNIP interaction and reduction of Trx activity were observed in the diabetic heart
before MI and were further ampliﬁed after MI. TXNIP siRNA or rhTrx treatment
counteracted the impairment of angiogenesis and alleviated myocardial ischemic
injury in diabetic mice. In vitro, TXNIP siRNA administration decreased apoptosis,
increased migration activity, and improved angiogenic capacity partly via increase of
VEGF secretion in HUVECs under high glucose stimulation.
Conclusions: Our study demonstrated for the ﬁrst time that TXNIP functions as an
important regulator in diabetes-induced impairment of angiogenesis and thereby
exacerbated myocardial ischemia injury through coordinately targeting Trx in endo-
thelial cells. Blockade of Trx/TXNIP interaction or supplementation of exogenous
rhTrx, might represent avenues for therapeutic exploitation to improve prognosis in
diabetic individuals with coronary artery disease.
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Role of Dyrk1A-ASF-CaMKIId Signaling Pathway in Rats with Chronic Heart
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Objectives: Recent studies have revealed the central contribution of alternative
splicing factor (ASF) -regulated calcium/calmodulin-dependent protein kinase IId
(CaMK IId) alternative splicing to pathological cardiac remodeling. ASF can be
phosphorylated by dual-speciﬁcity tyrosine-phosphorylated and regulated kinase 1A
(Dyrk1A). Furthermore, recently we found there is a signaling pathway of Dyrk1A-
ASF-regulated alternative slicing of CaMK IId. Here we aimed to explore whether the
Dyrk1A-ASF-CaMKIId pathway involved in the progression of heart failure in
myocardial infarction rats.
Methods: Myocardial infarction (MI) was induced by ligation of the left anterior
descending coronary artery. Left ventricular internal diameter at end-diastole (LVIDd)
and ejection fraction (EF), fraction shorten (FS) were measured by ultrasound echo-
cardiography. Protein expressions of Dyrk1A and ASF were determined by western
blot, furthermore the phosphorylation of ASF was determined by two-dimension
electropholysis. Alternative splicing of CaMK IId was measured by real-time PCR.
Results: 7 weeks later, we found that MI rats showed an increase in the ratio of left
ventricular weight to heart weight and LVIDd accompanied by a sharply decrease in
EF and FS (P<0.05), which indicated that MI rats had developed signiﬁcant heart
failure. Meantime, Dyrk1A expression and activity were elevated, the phosphorylation
of ASF was increased and there was the dysregulation of CaMK IId alternative
splicing, show as an increase in CaMK IIdA and dC, and a decrease in CaMK IIdB (all
P<0.05) in the MI rats. Conversely, treatment of MI rats with Dyrk1A inhibitor-
Harmine or EGCG effectively attenuated heart failure and reversed the molecular
changes of Dyrk1A, ASF and alternative splicing of CaMKIId caused by MI (all
P<0.05).
Conclusions: Enhanced activation of Dyrk1A-ASF-CaMKIId pathway participate in
heart failure caused by MI. Inhibition the signaling pathway can improve cardiac
function in MI.
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Objectives: Inspired by the effect of resistance to heart failure and Inhibition of
myocardial hypertrophy of astragalus,we proceed to study the possibility of the in-
hibition effect on myocardial remodeling of astragalus. Protein kinase C (protein ki-
nase C, PKC) is the key nodes on the signal transduction pathways of myocardial
hypertrophy, the PKC as research targets is a new way of effective prevention and
control of ventricular remodeling. This study was to explore the effect of astragalus
injection on the adjustment of PKC and impacts on ventricular remodeling in rats after
myocardial infarction.
Methods: 36 Wistar rats were divided into three groups: 12 rats in control group
(SHAM) : intraperitoneal injection of physiological saline 2mL bid6d. Coronary
artery was ligatured except day 7. 12 rats in ischemia reperfusion group (Model) :
intraperitoneal injection of physiological saline 2 mL bid6d. Simple ligatured
IAD in day 7,reperfusion 2h after 30min. 12 rats in astragalus treatment group
(Model + AS) : intraperitoneal injection of astragalus injection 4 g/2ml,bid6 d.
ligatured IAD in day 7,reperfusion 2h after 30min. At 1 week after ligation, we
observed the survival situation of all the rats. The echocardiographic examination
was made to inspect the LVEDD (left ventricular end diastolic diameter), LVESD
(left ventricular end systolic diameter), LVEF (left ventricular ejection fraction) andasic and Translational Medicine C19
LVFS (left ventricular fraction shortening). Detection of plasma BNP (brain
natriuretic peptide), and Masson staining determination of CVF (Collagen Volume
Fraction), immunohistochemical detection of PKCa and PKCε in myocardial tis-
sue, detection the PKCa and PKCε expression in myocardial cells by Western
blot.
Results: In group Model + AS, the death number is less than the Model group, the
cardiac function indexes have been improved and the myocardial ﬁbrosis degree
signiﬁcantly reduced compared with the Model group. The expression of PKCa in the
Model group is higher than in the Model+AS group; while the expression of PKCε in
Model group is lower than the Model + AS group.
Conclusions: The pretreatment of astragalus in myocardial infarction model rats can
inhibit the ventricular remodeling, and this effect may be caused by the up-regulation
of PKCε and the inhibition of PKCa expression.
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Objectives: Recent studies indicate ubiquitin-proteasome system particularly the E3
ubiquitin ligase plays a key role in cardiac hypertrophy. Neuregulin receptor degra-
dation protein-1 (Nrdp1) is a newly identiﬁed E3 ligase. In this study, we sought to
investigate the probability of knockdown of Nrdp1 might exhibit prohypertrophic
effects, and therefore we tested this hypothesis in vitro.
Methods: Neonatal cardiomyocytes were infected with adenovirus containing empty
vector (Ad-siRNA -control) and siRNA-Nrdp1 (Ad-siRNA-Nrdp1), and treated with
angiotensin II for 24 hours. Quantitative real-time PCR was used to determine the
expression of hypertrophy marker genes. Immunoﬂuorescence and were performed to
measure the cell surface area. Western blotting analysis was used to detect the
expression of phosphorylation of Akt and ERK1/2.
Results: After stimulated by angiotensinII, cell surface area of cardiomyocytes was
increased by 1.3-fold in Ad-siRNA-Nrdp1 group compared with Ad-siRNA-control
group (P<0.05). Furthermore, the mRNA levels of ANF,b-MHC and skeletal a-actin
in Ad-siRNA-Nrdp1 group was 1.5-fold, 1.4-fold, 1.5-fold higher than that of
Ad-siRNA-control group respectively (P<0.05). Knockdown of Nrdp1 augmented the
phosphorylation level of Akt (0.750.04 arbitrary units vs 0.290.03 arbitrary units,
P<0.05) and ERK1/2 (0.840.04 arbitrary units vs 0.270.04 arbitrary units,
P<0.05) compared with control group.
Conclusions: Knockdown of Nrdp1 might accelerate pathology progress of cardiac
hypertrophy, which may rely on promotion of the phosphorylation level of Akt and
ERK1/2.
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Objectives: To evaluate the transfection efﬁciency using recombinant adeno-asso-
ciatedvirus serotype 9 (rAAV9) mediated anti-nuclear factor-kB (NF-kB) ribozyme
and enhanced green ﬂuorescent protein (rAAV9-EGFP-R65) in Human Umbilical
Vein Endothelial Cells (HUVECs) and in Human Aortic Smooth Muscle Cells
(HASMCs), and to assess the inﬂuence of cell proliferation from the virus vector and
the P65 expressionof the NF-kB pathway.
Methods: HUVECs and HASMCs were respectively transfected with AAV9-eGFP-
R65at different Multiplicity of Infection (MOI¼ 1105, 1106 and 1107 v.g./cel1),
and the two kinds of cells were observed and analyzed with ﬂuorescence microscopy
and ﬂow cytometry to assess the transfection efﬁciency. Alamar Blue assay was used
to assess the proliferation of the transfected cells in HUVECsand HASMCs.Western
blot was used in detection P65 protein expression of NF-kB signaling pathway in
HUVECs and HASMCs.
Results: The ﬂuorescence intensity was enhanced with the increaseing of MOI and
time of transfection.HUVECs and HASMCs transfected with AAV9-eGFP-R65 were
begin to express after transfected 24 hours, and the expression peak appeared in the
sixth day in HUVECs, and the ﬁfth day in HASMCs. Multiplicity of infection of
1105, 1106 and 1107in the sixth day after transfection in HUVECs was
(1.401.20)%, (12.301.35)% and (52.802.05)%.And the ﬁfth day in HASMCs
was (5.301.04)%, (18.302.24)% and (52.403.21)%. Cell growth was not affected
and cell form was normal inthe whole observation period. Alamar Blue assay did
notreveal signiﬁcant diference in the absorbance between the transfected cells and the
control cells in the two kinds of cells. Western blotting showed that the expression of
P65 of NF-kB signaling pathway was decreased by the AAV9-eGFP-R65 in two cells.
Conclusions: HUVECs and HASMCs can be efﬁciently transfected by AAV9-eGFP-
R65, and there was no proliferation inhibition between the two kinds of cells. And
P65 expression was restrained by the rAAV9-eGFP-R65 in both HUVECs and
HASMCs.C20 JACC Vol 64/16/Suppl C j OctobGW25-e3134
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Objectives: Cytochrome P450 (CYP) 2C9 catalyzes a wide spectrum of drugs and is
also responsible for the metabolism of arachidonic acid to biologically active epox-
yeicosatrienoic acids (EETs). EETs are known to be a vasoactive substance and play
an important role in a hypertensive episode. The aim of the present study was to assess
the association between the human CYP2C9 gene and essential hypertension (EH) in
Chinese Population.
Methods:We use two independent case-control studies: a Han population (267 EH
patients and 253 control subjects) and a Uygur population (220 EH patients and
166 control subjects). All EH patients and controls were genotyped for the same
four single nucleotide polymorphisms (SNPs) (rs4086116, rs2475376, rs1057910
and rs1934967) of CYP2C9 gene by a Real-time PCR instrument. The data was
assessed for 3 groups: total, men, and women via Haplotype-based case-control
studies.
Results: It was not found that the statistically signiﬁcant differences in the distribution
of the allele and genotype frequencies of CYP2C9 between the EH patients and
control participants both in Han population and in Uygur population (P>0.05, all).
When using Haplotype-based case-control studies, we still did not ﬁnd all the hap-
lotypes in CYP2C9 gene were signiﬁcant different between EH patients and control
subjects (P>0.05, all).
Conclusions: These results suggest that these SNPs of CYP2C9 gene are not asso-
ciated with increased/decreased risk of hypertension in the Chinese population.
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Objectives: GP78 is a membrane-anchored ubiquitin ligase mediating the degradation
of HMG-CoA reductase (HMGCR) and Insig-1, which was very essential for the
synthesis of cholesterol process. The cholesterol has a causal role in the development
of cardiovascular disease. The aim of the present study was to assess the association
between the human gp78 gene polymorphism and coronary artery disease (CAD) in a
Han and Uygur population of China.
Methods: We use two independent case-control studies: a Han population (602 CAD
patients and 572control subjects) and a Uygur population (374 CAD patients and
376control subjects). All CAD patients and controls were genotyped for the same
three single nucleotide polymorphisms (SNPs) (rs731119, rs2617849and rs2440472)
of gp78 gene by a Real-time PCR instrument.
Results: the Han population, for total and men, the distribution of SNP3 (rs2440472)
genotypes showed a signiﬁcant difference between CAD and control participants (for
total: P¼0.008, for men: P¼0.007), the distribution of SNP3 (rs2440472) alleles and
the dominant model (AA vs AG+GG) and recessive model (GG vs AG+AA) showed
a signiﬁcant difference between CAD and control participants (for allele: P¼0.003 and
P¼0.002, respectively; for dominant model: P¼0.041 and P¼0.026, respectively; for
recessive model: P¼0.004 and P¼0.004, respectively). The signiﬁcant difference in
both the two models was retained after adjustment for covariates (for dominant model
P¼0.042 and P¼0.022, respectively; for recessive model P¼0.018 and P¼0.000,
respectively).
Conclusions: The GG genotype and G allele of rs2440472 in gp78 gene could be a
risk genetic marker of CAD in Han population in China.
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Changes in levels of angiotensin II and its receptors in a model of stress-induced
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Objectives: Stress-induced cardiomyopathy (SIC) is characterized by extensive
ventricular akinesis involving apical segments with preserved function in basal seg-
ments. Beta-blockers and angiotensin-converting enzyme inhibitors (ACEIs) are the
main treatments for SIC. We assessed changes in levels of angiotensin II, angio-
tension-II receptors and ACE responses to SIC.
Methods: A model of SIC was established in rabbits by vagal electrical stimulation.
The serum concentration of angiotensin II and angiotensin (1-7) was detected by
enzyme-linked immunosorbent assay. Expression of angiotensin-II receptors was
measured by western blotting and real-time RT-PCR, with localization detected by
immunoﬂuorescent staining. ACE-II expression in the myocardium was measured by
western blotting.er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
